Fluorine-19 NMR studies of tumor-bearing rats treated with difluoromethylornithine
- 1 February 1987
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 4 (2), 137-143
- https://doi.org/10.1002/mrm.1910040206
Abstract
Copenhagen rats with implanted metastatic prostate carcinomas have been treated with the drug α‐difluoromethylornithine (DFMO), an inhibitor of the enzyme ornithine decarboxylase. In vivo and in vitro 19F NMR observations were then carried out on a variety of organs and tissues. The distribution of the drug strongly favored tumor over surrounding muscle. DFMO, which gives a spectrum similar to that of the pH indicator difluoromethylalanine, has potential for determination of in vivo pH. However, in contrast to the alanine analog, DFMO exhibits a considerably smaller shift dependence in response to pH changes. © 1987 Academic Press, Inc.This publication has 16 references indexed in Scilit:
- An approach to NMR studies of the metabolism of internal organs using surface coilsJournal of Biochemical and Biophysical Methods, 1985
- In Vivo 19F NMR ImagingJournal of Computer Assisted Tomography, 1985
- The fluorinated anesthetic halothane as a potential NMR biologic probeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1984
- 5-Flourouracil metabolism monitored in vivo by 19F NMRBritish Journal of Cancer, 1984
- Chemotherapeutic implications of polyamine biosynthesis inhibitionClinical Pharmacology & Therapeutics, 1984
- Noninvasive Observations of Fluorinated Anesthetics in Rabbit Brain by Fluorine-19 Nuclear Magnetic ResonanceScience, 1983
- Fluorinated alpha-methylamino acids as 19F NMR indicators of intracellular pHBiophysical Journal, 1983
- Pulmonary MicroangiographyInvestigative Radiology, 1983
- Regulation of intracellular pH by human peripheral blood lymphocytes as measured by 19F NMR.Proceedings of the National Academy of Sciences, 1982
- Copenhagen rat prostatic tumor ornithine decarboxylase activity (ODC) and the effect of the ODC inhibitor alpha-difluoromethylornithineThe Prostate, 1982